Document is current
Any future updates will be listed below
-
Authors
Ito, Miyuki
Maeda, Daichi
Matsue, Yuya
Shiraishi, Yasuyuki
Dotare, Taishi
Sunayama, Tsutomu
Nogi, Kazutaka
Takei, Makoto
Ueda, Tomoya
Nogi, Maki
Ishihara, Satomi
Nakada, Yasuki
Kawakami, Rika
Kagiyama, Nobuyuki
Kitai, Takeshi
Oishi, Shogo
Akiyama, Eiichi
Suzuki, Satoshi
Yamamoto, Masayoshi
Kida, Keisuke
Okumura, Takahiro
Nagatomo, Yuji
Kohno, Takashi
Nakano, Shintaro
Kohsaka, Shun
Yoshikawa, Tsutomu
Saito, Yoshihiko
Minamino, Tohru
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (22K16152)
Japan Society for the Promotion of Science (21H03309)
Japan Society for the Promotion of Science (18K15860)
Japan Society for the Promotion of Science (21H03309)
Japan Society for the Promotion of Science (17K09526)
Japan Society for the Promotion of Science (23591062)
Japan Society for the Promotion of Science (18K15860)
the Cardiovascular Research Fund of Japan
Japan Agency for Medical Research and Development (201439013C)
Sakakibara Clinical Research Grants for the Promotion of Science
- License Information
-
More Information
Article History
Received: 18 April 2022
Accepted: 20 September 2022
First Online: 5 October 2022
Competing interests
: Y.M. received an honorarium from Otsuka Pharmaceutical Co, Novartis Japan, and Bayer Japan, and a collaborative research grant from Pfizer Inc. Y.Sh. received honoraria from Otsuka, Ono, and personal fees from Nippon Shinyaku, Medtronic Japan, and Biotronik outside the submitted work. K.K. received honoraria from Daiichi-Sankyo, Ono, AstraZeneca, Otsuka, and Novartis outside the submitted work. T.O. received honoraria from Ono, Otsuka, Novartis, and AstraZeneca and research grants from Ono, Amgen, Pfizer, Alnylam, and Alexion outside the submitted work. S.K. received honoraria from Bayer and research grants from Novartis outside the submitted work. Other authors declare no competing interests.
